| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.01 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |